Skip to content

Mannkind MNKD Stock-Based Comp

Stock-Based Comp at other companies

Eli Lilly logo
Eli LillyLLY
$161M+4.5%
LQD
Liquidia CorporationLQDA
$9.22M+23.9%
Tenet Healthcare logo
Tenet HealthcareTHC
$25M+19.0%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$3.08M+1.2%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$6.55M+79.6%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$15.66M-38.6%

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.21B+6.0%
Enterprise value$1.17B+5.5%
P/E233.9×
P/S3.4×-0.5×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's stock-based comp?
Mannkind (MNKD) reported stock-based comp of $6.46M in Q1 2026.
How has Mannkind's stock-based comp changed year-over-year?
Mannkind's stock-based comp increased by 19.9% year-over-year, from $5.39M to $6.46M.
What is the long-term trend for Mannkind's stock-based comp?
Over 4 years (2021 to 2025), Mannkind's stock-based comp has grown at a 18.7% compound annual growth rate (CAGR), from $12.2M to $24.2M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.